The Medical Foods and Formulas Access Act of 2025 would require Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program to cover medically necessary food for people with specific digestive and metabolic disorders. This includes specialized formulas and nutrients prescribed by healthcare providers for conditions like inherited metabolic disorders, inflammatory bowel disease, and food protein allergies. The bill defines "medically necessary food" to include items such as amino acid preparations, low protein modified foods, and vitamins specifically designed for these conditions, along with necessary medical equipment for administration. Coverage would apply to federal health programs with different effective dates (1-3 years from enactment) and encourages private health insurance plans to provide similar coverage for these life-sustaining treatments.
The Keep Kids Covered Act extends continuous health coverage for children enrolled in Medicaid and CHIP. It requires states to maintain coverage for newborns and young children until age 6 (previously 1 year), for children ages 6-18 until age 19 (previously 12 months), and for former foster youth until age 26 (previously 18). The bill also mandates states to update contact information annually for long-term enrollees and inform them about their coverage duration. These changes aim to prevent gaps in health insurance for vulnerable children and youth. The provisions take effect one year after the bill's enactment.
This bill requires hospitals to screen all infants under 21 days old for congenital cytomegalovirus (CMV), a common viral infection that can cause hearing loss and developmental delays. It directs state health officials to establish screening standards and procedures, with the federal Advisory Committee stepping in if states fail to act within two years of the law's enactment. The bill authorizes funding through the Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health to support state screening programs, data systems, healthcare provider training, and research on CMV screening and treatments. These provisions directly affect newborns in hospitals, healthcare providers administering tests, and state public health agencies implementing the screening requirements.
HR 3266, the Mental Health Infrastructure Improvement Act of 2025, provides federal loans and loan guarantees to help build or upgrade mental health and substance use disorder treatment facilities. It directly affects eligible entities like hospitals, clinics, and community facilities - especially those serving pediatric or adult patients in underserved rural areas or communities with insufficient psychiatric bed capacity. Key provisions include requiring borrowers to cover 25% of project costs, prioritizing projects that increase bed availability in high-need areas, and capping annual funding at $200 million (2026-2030). The bill establishes specific terms for loans, such as 20-year maximum terms and a 25% set-aside for pediatric facilities, to expand access to inpatient and outpatient care.
The Healthy Moms and Babies Act (S 2289) aims to improve maternal and infant health outcomes by strengthening Medicaid and CHIP programs. It requires states to report on maternal health quality measures, establishes a new "maternity health home" option for coordinated care during pregnancy and postpartum, and mandates studies on reducing cesarean sections and expanding doula services under Medicaid. The bill also requires states to collect data on social determinants of health affecting pregnant and postpartum women and provides guidance for reducing maternal mortality and severe morbidity. These provisions directly affect pregnant and postpartum women enrolled in Medicaid, healthcare providers, and state Medicaid programs.
This bill requires Medicaid and CHIP programs to cover tobacco cessation counseling and FDA-approved medications (including nonprescription options) with no out-of-pocket costs for enrollees. It directly affects low-income individuals using tobacco products who are enrolled in Medicaid or CHIP. Key mechanisms include a temporary 90% federal funding share for these services for five years, prohibitions on prior authorization for cessation drugs, and requirements for states to promote these services through outreach campaigns. The law also mandates states to monitor and increase awareness of these covered benefits among tobacco users and healthcare providers.
HR 4104 would expand access to Medicaid, CHIP, and Affordable Care Act (ACA) health coverage for immigrants lawfully present in the U.S., including those with deferred action or pending immigration applications. It removes state-level barriers to Medicaid/CHIP eligibility for lawfully present individuals, treats Federally authorized presence as "lawfully present" for ACA subsidies, and allows states to choose to cover undocumented individuals through Medicaid or CHIP. The bill also extends these changes to Medicare Part A and Part B, ensuring lawfully present immigrants qualify for coverage and subsidies under existing programs. These provisions apply to all federally funded health programs and take effect in 2026 for most ACA-related changes.
This bill requires hospitals and obstetric providers to disclose policies on providing life-saving care to premature infants, directly affecting parents expecting premature births and healthcare facilities. Hospitals must publicly state if they have a minimum gestational age for treatment, whether care decisions are case-by-case, and transfer plans for infants needing higher-level care. Obstetric providers must share these policies with patients during the first prenatal visit. Non-compliant hospitals and providers risk losing federal Medicaid and CHIP funding starting January 2026. The law aims to ensure transparency about neonatal care options before delivery.
This bill reauthorizes and updates federal programs for newborn screening, primarily affecting infants, children with genetic conditions, and their families. It increases annual funding for screening programs to $20.8 million (2026-2030) and research to $22.25 million, requiring states to develop parent education materials on screening follow-up and treatment. Key provisions include creating a public clearinghouse for screening data, improving coordination between state health programs, and mandating that research on genetic testing must consult with state health departments. The bill also updates deadlines for advisory committee work and technical assistance for screening panels through 2030.
HRES 955 is a symbolic House resolution recognizing the importance of maintaining U.S. leadership in ending pediatric HIV/AIDS globally. It affirms support for existing programs like PEPFAR and the Global Fund, which provide critical prevention services (e.g., antiretroviral prophylaxis for pregnant women) and treatment for children. The resolution specifically calls for continued commitment to closing the treatment gap for children, expanding access to long-acting prevention methods, and advancing the Global Alliance to End AIDS in Children by 2030. As a recognition measure, it does not create new laws or allocate funding but underscores ongoing U.S. efforts to prevent mother-to-child transmission and improve pediatric HIV outcomes.
